What to expect from targeted therapy for chronic myeloid leukaemia

Chronic myeloid leukaemia is driven by an abnormal signal in blood-forming cells. Targeted medicines called tyrosine kinase inhibitors block that signal. They are usually tablets, so treatment can often be managed at home after you receive clear instructions.

Your team will use blood counts and specialised tests to measure how the leukaemia is responding. Reviews also cover how regularly you take the tablets, because missed doses can affect control. Side effects vary by medicine and may include tiredness, muscle cramps, nausea, loose stools, skin changes, headache or fluid retention.

Take the tablet exactly as directed and ask whether it must be separated from meals. Use a reminder or treatment diary, store it safely, and never double a dose after forgetting one without advice. Tell your team about every prescription, over-the-counter medicine and supplement before adding it.

Keep scheduled blood tests even when symptoms are absent. Mention swelling, breathlessness, persistent diarrhoea, cramps, new rash, unusual tiredness or changes in vision. Your clinician may adjust the dose or choose another inhibitor if side effects or test results require it.

Contact the treatment team quickly for fever, signs of infection, severe vomiting or diarrhoea, sudden swelling, reduced urine, yellowing of the skin, or unusual bleeding. Seek emergency care for chest pain, severe breathlessness, fainting, sudden confusion, or swelling of the lips or throat.

Ask which blood tests will track response, how to take your tablet with food, what to do after a missed dose, which interactions matter, and how the team will decide whether to continue, adjust or change treatment.